The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cancer Genome Sequencing-Global Market Insights and Sales Trends 2024
Synopsis
Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or heterogeneous group of tumor cells.
The global Cancer Genome Sequencing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Genome Sequencing in various end use industries. The expanding demands from the Treatment and Research, are propelling Cancer Genome Sequencing market. Second Generation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Third Generation segment is estimated at % CAGR for the next seven-year period.
It is a laboratory technique that characterizes DNA or RNA sequences of primary tumor tissue, the tumor micro environment (such as stromal / fibroblast cells), adjacent or distal normal tissue, or metastatic tumor sites. This technique generates information related to identification of nucleotide bases (DNA or RNA), mutation status, copy number and sequence variants, as well as structural variations including fusion genes and chromosomal translocations.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Genome Sequencing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Genome Sequencing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Genome Sequencing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Genome Sequencing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Genome Sequencing covered in this report include Agilent Technologies, GE Healthcare Life Sciences, Johnson & Johnson, LI-COR Biosciences, Abbott Laboratories, Beckman Coulter, Bayer, Hamilton Thorne Biosciences and Integrated DNA Technologies, etc.
The global Cancer Genome Sequencing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agilent Technologies
GE Healthcare Life Sciences
Johnson & Johnson
LI-COR Biosciences
Abbott Laboratories
Beckman Coulter
Bayer
Hamilton Thorne Biosciences
Integrated DNA Technologies
Microchip Biotechnologies
Myriad Genetics
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences
Global Cancer Genome Sequencing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Genome Sequencing market, Segment by Type:
Second Generation
Third Generation
Global Cancer Genome Sequencing market, by Application
Treatment
Research
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cancer Genome Sequencing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or heterogeneous group of tumor cells.
The global Cancer Genome Sequencing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Genome Sequencing in various end use industries. The expanding demands from the Treatment and Research, are propelling Cancer Genome Sequencing market. Second Generation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Third Generation segment is estimated at % CAGR for the next seven-year period.
It is a laboratory technique that characterizes DNA or RNA sequences of primary tumor tissue, the tumor micro environment (such as stromal / fibroblast cells), adjacent or distal normal tissue, or metastatic tumor sites. This technique generates information related to identification of nucleotide bases (DNA or RNA), mutation status, copy number and sequence variants, as well as structural variations including fusion genes and chromosomal translocations.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Genome Sequencing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Genome Sequencing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Genome Sequencing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Genome Sequencing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Genome Sequencing covered in this report include Agilent Technologies, GE Healthcare Life Sciences, Johnson & Johnson, LI-COR Biosciences, Abbott Laboratories, Beckman Coulter, Bayer, Hamilton Thorne Biosciences and Integrated DNA Technologies, etc.
The global Cancer Genome Sequencing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agilent Technologies
GE Healthcare Life Sciences
Johnson & Johnson
LI-COR Biosciences
Abbott Laboratories
Beckman Coulter
Bayer
Hamilton Thorne Biosciences
Integrated DNA Technologies
Microchip Biotechnologies
Myriad Genetics
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences
Global Cancer Genome Sequencing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Genome Sequencing market, Segment by Type:
Second Generation
Third Generation
Global Cancer Genome Sequencing market, by Application
Treatment
Research
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cancer Genome Sequencing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cancer Genome Sequencing
1.1 Cancer Genome Sequencing Market Overview
1.1.1 Cancer Genome Sequencing Product Scope
1.1.2 Cancer Genome Sequencing Market Status and Outlook
1.2 Global Cancer Genome Sequencing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cancer Genome Sequencing Market Size by Region (2018-2029)
1.4 Global Cancer Genome Sequencing Historic Market Size by Region (2018-2023)
1.5 Global Cancer Genome Sequencing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cancer Genome Sequencing Market Size (2018-2029)
1.6.1 North America Cancer Genome Sequencing Market Size (2018-2029)
1.6.2 Europe Cancer Genome Sequencing Market Size (2018-2029)
1.6.3 Asia-Pacific Cancer Genome Sequencing Market Size (2018-2029)
1.6.4 Latin America Cancer Genome Sequencing Market Size (2018-2029)
1.6.5 Middle East & Africa Cancer Genome Sequencing Market Size (2018-2029)
2 Cancer Genome Sequencing Market by Type
2.1 Introduction
2.1.1 Second Generation
2.1.2 Third Generation
2.2 Global Cancer Genome Sequencing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cancer Genome Sequencing Historic Market Size by Type (2018-2023)
2.2.2 Global Cancer Genome Sequencing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cancer Genome Sequencing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cancer Genome Sequencing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cancer Genome Sequencing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cancer Genome Sequencing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cancer Genome Sequencing Revenue Breakdown by Type (2018-2029)
3 Cancer Genome Sequencing Market Overview by Application
3.1 Introduction
3.1.1 Treatment
3.1.2 Research
3.2 Global Cancer Genome Sequencing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cancer Genome Sequencing Historic Market Size by Application (2018-2023)
3.2.2 Global Cancer Genome Sequencing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cancer Genome Sequencing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cancer Genome Sequencing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cancer Genome Sequencing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cancer Genome Sequencing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cancer Genome Sequencing Revenue Breakdown by Application (2018-2029)
4 Cancer Genome Sequencing Competition Analysis by Players
4.1 Global Cancer Genome Sequencing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Genome Sequencing as of 2022)
4.3 Date of Key Players Enter into Cancer Genome Sequencing Market
4.4 Global Top Players Cancer Genome Sequencing Headquarters and Area Served
4.5 Key Players Cancer Genome Sequencing Product Solution and Service
4.6 Competitive Status
4.6.1 Cancer Genome Sequencing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Agilent Technologies
5.1.1 Agilent Technologies Profile
5.1.2 Agilent Technologies Main Business
5.1.3 Agilent Technologies Cancer Genome Sequencing Products, Services and Solutions
5.1.4 Agilent Technologies Cancer Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.1.5 Agilent Technologies Recent Developments
5.2 GE Healthcare Life Sciences
5.2.1 GE Healthcare Life Sciences Profile
5.2.2 GE Healthcare Life Sciences Main Business
5.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Products, Services and Solutions
5.2.4 GE Healthcare Life Sciences Cancer Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.2.5 GE Healthcare Life Sciences Recent Developments
5.3 Johnson & Johnson
5.3.1 Johnson & Johnson Profile
5.3.2 Johnson & Johnson Main Business
5.3.3 Johnson & Johnson Cancer Genome Sequencing Products, Services and Solutions
5.3.4 Johnson & Johnson Cancer Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.3.5 LI-COR Biosciences Recent Developments
5.4 LI-COR Biosciences
5.4.1 LI-COR Biosciences Profile
5.4.2 LI-COR Biosciences Main Business
5.4.3 LI-COR Biosciences Cancer Genome Sequencing Products, Services and Solutions
5.4.4 LI-COR Biosciences Cancer Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.4.5 LI-COR Biosciences Recent Developments
5.5 Abbott Laboratories
5.5.1 Abbott Laboratories Profile
5.5.2 Abbott Laboratories Main Business
5.5.3 Abbott Laboratories Cancer Genome Sequencing Products, Services and Solutions
5.5.4 Abbott Laboratories Cancer Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.5.5 Abbott Laboratories Recent Developments
5.6 Beckman Coulter
5.6.1 Beckman Coulter Profile
5.6.2 Beckman Coulter Main Business
5.6.3 Beckman Coulter Cancer Genome Sequencing Products, Services and Solutions
5.6.4 Beckman Coulter Cancer Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.6.5 Beckman Coulter Recent Developments
5.7 Bayer
5.7.1 Bayer Profile
5.7.2 Bayer Main Business
5.7.3 Bayer Cancer Genome Sequencing Products, Services and Solutions
5.7.4 Bayer Cancer Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.7.5 Bayer Recent Developments
5.8 Hamilton Thorne Biosciences
5.8.1 Hamilton Thorne Biosciences Profile
5.8.2 Hamilton Thorne Biosciences Main Business
5.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Products, Services and Solutions
5.8.4 Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.8.5 Hamilton Thorne Biosciences Recent Developments
5.9 Integrated DNA Technologies
5.9.1 Integrated DNA Technologies Profile
5.9.2 Integrated DNA Technologies Main Business
5.9.3 Integrated DNA Technologies Cancer Genome Sequencing Products, Services and Solutions
5.9.4 Integrated DNA Technologies Cancer Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.9.5 Integrated DNA Technologies Recent Developments
5.10 Microchip Biotechnologies
5.10.1 Microchip Biotechnologies Profile
5.10.2 Microchip Biotechnologies Main Business
5.10.3 Microchip Biotechnologies Cancer Genome Sequencing Products, Services and Solutions
5.10.4 Microchip Biotechnologies Cancer Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.10.5 Microchip Biotechnologies Recent Developments
5.11 Myriad Genetics
5.11.1 Myriad Genetics Profile
5.11.2 Myriad Genetics Main Business
5.11.3 Myriad Genetics Cancer Genome Sequencing Products, Services and Solutions
5.11.4 Myriad Genetics Cancer Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.11.5 Myriad Genetics Recent Developments
5.12 Commonwealth Biotechnologies
5.12.1 Commonwealth Biotechnologies Profile
5.12.2 Commonwealth Biotechnologies Main Business
5.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Products, Services and Solutions
5.12.4 Commonwealth Biotechnologies Cancer Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.12.5 Commonwealth Biotechnologies Recent Developments
5.13 ZS Genetics
5.13.1 ZS Genetics Profile
5.13.2 ZS Genetics Main Business
5.13.3 ZS Genetics Cancer Genome Sequencing Products, Services and Solutions
5.13.4 ZS Genetics Cancer Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.13.5 ZS Genetics Recent Developments
5.14 Pacific Biosciences
5.14.1 Pacific Biosciences Profile
5.14.2 Pacific Biosciences Main Business
5.14.3 Pacific Biosciences Cancer Genome Sequencing Products, Services and Solutions
5.14.4 Pacific Biosciences Cancer Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.14.5 Pacific Biosciences Recent Developments
6 North America
6.1 North America Cancer Genome Sequencing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cancer Genome Sequencing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cancer Genome Sequencing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cancer Genome Sequencing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cancer Genome Sequencing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cancer Genome Sequencing Market Dynamics
11.1 Cancer Genome Sequencing Industry Trends
11.2 Cancer Genome Sequencing Market Drivers
11.3 Cancer Genome Sequencing Market Challenges
11.4 Cancer Genome Sequencing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
